London, ON – London is stepping into the national spotlight this spring as leaders from across Canada’s biotech, healthcare, academic, and investment sectors gather for a transformative event designed to showcase innovation, talent, and collaboration.
Hosted by Medicenna Therapeutics and IMadeIt.ai, the London Calling - Medicenna's Biotech Milestones event will take place on Monday, April 14, 2025, from 5:00 PM to 9:00 PM at The Great Hall of Somerville House, Western University.
This high-impact evening will unite over 100 professionals and 40+ top-performing high school students who are actively engaged in real-world co-op projects through IMadeIt.ai’s unique experiential learning model.
Featured Guest Speakers:
- Dr. Fahar Merchant – President & CEO, Medicenna Therapeutics
- Dr. John H. Sampson (Taped) – Professor of Neurosurgery, Duke University School of Medicine
- Dr. Arash Yavari (Taped) – Research Lecturer & Principal Investigator, University of Oxford
- Dr. Robert Arntfield – Founder & CEO, Deep Breathe; Medical Director, LHSC Trauma Centre
- Dr. Fred Possmayer – Co-founder of BLES Biochemicals Inc.
- Justin Leushner – Executive, Advisor, and Board Member in Medtech & Life Sciences
Event Highlights:
- Keynote address by Dr. Fahar Merchant, a proud Western University alumnus and pioneer in cancer immunotherapy
- Fireside chats and panel discussions with top minds in biotech, medtech, and education
- Immersive conversations with high school innovators actively contributing to public companies through IMadeIt.ai
“I’m excited to be able to highlight the success of Canadian biotech, especially in light of Medicenna’s recent achievements and potential to transform the lives of patients,” remarked Dr. Fahar Merchant, President and CEO of Medicenna. “Elevating awareness of home grown innovation is an important initiative, and London is a place close to my heart given it’s foundational impact on my journey in the biomedical field.”
“This isn’t just another dinner—it’s a movement,” says Shelly Zheng, CEO of IMadeIt.ai. “We’re building bridges between sectors and generations, and we’re doing it in a city that’s ready to lead Canada’s next chapter in medical innovation.”
The event will also offer media exclusive access to industry leaders and students, highlighting London’s growing reputation as a national hub for biotech and health innovation.
Media are invited to attend. Interviews, coverage opportunities, and media kits are available upon request.
This event is by invitation only. To request an invitation or inquire further, please contact: Alex Gu via agu@imadeit.life
Event Details:
Location: The Great Hall of Somerville House, Western University, London, ON
Date: Monday, April 14, 2025
Time: 5:00 PM – 9:00 PM
The event is invite only, please contact: Alex Gu, agu@imadeit.life for applying for the event.
Head of IR & Business Development, IMadeIt.ai
agu@imadeit.life
+1 (647) 571-9529
www.imadeit.ai
About Medicenna Therapeutics
Medicenna is a clinical-stage immunotherapy company developing novel, highly selective Superkine therapies to treat cancer and autoimmune diseases. Medicenna has several therapies in development, with its lead program targeting difficult-to-treat cancers for patients that have failed prior treatment. It also has a therapy in late-stage development for recurrent glioblastoma, a rare and aggressive type of brain cancer.
About IMadeIt.ai
IMadeIt.ai bridges the gap between education and industry by empowering high school students to work on real-world projects with public companies, helping to shape Canada’s next generation of leaders.
